Illinois gets $1.3 million in drug settlement

Published



CHICAGO (AP) — Illinois will receive $1.3 million as part of a $35 million settlement with a pharmaceutical company over the marketing of an organ-transplant drug.

Illinois and 41 other states are involved in the settlement with Pfizer Inc., the parent company of Wyeth Pharmaceuticals Inc. The deal resolves allegations Wyeth misrepresented the uses of the drug Rapamune.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.